PRDMX
Price
$45.60
Change
-$0.05 (-0.11%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

PRDMX vs RPTIX

Header iconPRDMX vs RPTIX Comparison
Open Charts PRDMX vs RPTIXBanner chart's image
T. Rowe Price Diversified Mid Cap Gr
Price$45.60
Change-$0.05 (-0.11%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PRDMX vs RPTIX Comparison Chart
Loading...
VS
PRDMX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRDMX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. PRDMX (2.46B). RPTIX pays higher dividends than PRDMX: RPTIX (0.18) vs PRDMX (0.00). PRDMX was incepted earlier than RPTIX: PRDMX (21 years) vs RPTIX (9 years). PRDMX is a more actively managed with annual turnover of: 49.70 vs. RPTIX (21.70). PRDMX has a lower initial minimum investment than RPTIX: PRDMX (2500) vs RPTIX (500000). PRDMX annual gain was more profitable for investors over the last year : 20.67 vs. RPTIX (14.81). PRDMX return over 5 years is better than : 30.91 vs. RPTIX (15.09).
PRDMXRPTIXPRDMX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years9 years-
Gain YTD14.4299.127158%
Front LoadN/AN/A-
Min. Initial Investment25005000001%
Min. Initial Investment IRAN/AN/A-
Net Assets2.46B31.4B8%
Annual Yield % from dividends0.000.18-
Returns for 1 year20.6714.81140%
Returns for 3 years-12.02-13.5789%
Returns for 5 years30.9115.09205%
Returns for 10 years95.29N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp